Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bionet TherapeuticsROCO:7808 12 Market Cap is NT$2,170.0 Mil as of Jul. 15, 2026. GuruFocus rates ROCO:7808 with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 1,423 Biotechnology companies, Bionet Therapeutics ranks worse than 58.47% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Bionet Therapeutics's share price for the quarter that ended in Dec. 2025 was NT$56.2. Bionet Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 70.0 Mil. Therefore, Bionet Therapeutics's market cap for the quarter that ended in Dec. 2025 was NT$3,934.0 Mil.
Bionet Therapeutics's quarterly market cap
declined
from Dec. 2024 (NT$3,262.0 Mil) to Jun. 2025 (NT$2,961.0 Mil) but then
increased
from Jun. 2025 (NT$2,961.0 Mil) to Dec. 2025 (NT$3,934.0 Mil).
Bionet Therapeutics's annual market cap
increased
from Dec. 2023 (NT$0.0 Mil) to Dec. 2024 (NT$3,262.0 Mil) and
increased
from Dec. 2024 (NT$3,262.0 Mil) to Dec. 2025 (NT$3,934.0 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Bionet Therapeutics's Enterprise Value for Today is NT$1,121.1 Mil.
Bionet Therapeutics (ROCO:7808) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Bionet Therapeutics Market Cap Related Terms
Bionet Therapeutics Market Cap Historical Data
* Premium members only.
The historical data trend for Bionet Therapeutics's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7808 vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, Bionet Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bionet Therapeutics Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bionet Therapeutics's Market Cap distribution charts can be found below:
* The bar in red indicates where Bionet Therapeutics's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Bionet Therapeutics's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bionet Therapeutics (ROCO:7808) has a Market Cap of NT$2,170.0 Mil as of Jul. 15, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bionet Therapeutics and its competitors. According to the industry distribution chart, Bionet Therapeutics ranks #832 out of 1423 companies in the Biotechnology industry, placing it in the top 58.5%.
Is Bionet Therapeutics' Market Cap too high?
Bionet Therapeutics' current Market Cap is NT$2,170.0 Mil. Based on the distribution chart, Bionet Therapeutics ranks #832 out of 1423 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Bionet Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bionet Therapeutics' Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bionet Therapeutics ranks #832 out of 1423 companies for Market Cap. This places Bionet Therapeutics in the lower half of its industry. The industry median Market Cap is 114.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 114.24, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bionet Therapeutics and its competitors. For the Biotechnology industry, the median Market Cap is 114.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bionet Therapeutics's current Market Cap is NT$2,170.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionet Therapeutics stock overvalued right now?
Bionet Therapeutics (ROCO:7808) has a current Market Cap of NT$2,170.0 Mil. The current Market Cap is NT$2,170.0 Mil. Bionet Therapeutics' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Bionet Therapeutics (ROCO:7808), the current Market Cap is NT$2,170.0 Mil as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bionet Therapeutics Corp is a patient-focused on regenerative medicinal products, R&D, exosomes, and gene/cell therapy biopharmaceutical company. The group develops, manufactures, and provides regenerative medicine preparations and cellular therapies to meet the evolving health needs of people at different stages of life. It focused on treatments that improve patient outcomes. It provides Cell Therapy Products and CRDMO Services.
12GF Score
Get the complete analysis for ROCO:7808
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7808 has been successfully added to your 
